Shares of CohBar, Inc. (NASDAQ:CWBR – Get Free Report) shot up 1% during mid-day trading on Wednesday . The company traded as high as $0.53 and last traded at $0.53. 1,324 shares were traded during trading, a decline of 50% from the average session volume of 2,672 shares. The stock had previously closed at $0.52.
CohBar Trading Up 1.0 %
The stock’s 50-day moving average is $0.50 and its 200-day moving average is $0.49.
CohBar Company Profile
CohBar, Inc, a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases.
Featured Articles
- Five stocks we like better than CohBar
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- The Great CPU Race: AMD and Intel Battle for Dominance
- Utilities Stocks Explained – How and Why to Invest in Utilities
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- Why Invest in 5G? How to Invest in 5G Stocks
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for CohBar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CohBar and related companies with MarketBeat.com's FREE daily email newsletter.
